Kratos vs. Rocket Lab: Which Under-the-Radar Defense Stock Will Make You Richer?

Kratos won a $1.45B MACH-TB 2.0 hypersonics contract (largest in company history) and projects its hypersonics business to double revenue to about $400M in 2026, while also ramping Valkyrie UAS work and participating on a $231.5M subcontract. Rocket Lab secured an $816M SDA Tranche 3 prime contract to design, build and operate 18 missile‑warning satellites and completed three HASTE suborbital tests; it remains unprofitable but is expanding its vertically integrated space systems and plans a Neutron launch. Analysts forecast 2028 non‑GAAP EPS of $0.29 for Rocket Lab (implying ~264x forward EPS) versus $1.34 for Kratos (~68x), making Kratos the cheaper, currently profitable pure‑play defense exposure and Rocket Lab a higher‑valuation, higher‑growth bet.

Analysis

Kratos and Rocket Lab are playing different games: one competes on margins inside defense programs, the other competes on cadence and end-to-end space delivery. The practical implication is that Kratos’ business model is more sensitive to margin expansion and production learning curves, whereas Rocket Lab’s value hinges on execution of capital-intensive, binary technology milestones (launches, large-build schedules).

A second-order beneficiary set is visible in the supply chain: firms supplying GaN/SiC microwave components, attritable avionics, and high-throughput assembly lines will see step-function demand if attritable systems scale, while specialty optics and outsourced payload houses face margin pressure from vertically integrated spacecraft manufacturers. Prime integrators win too — faster, cheaper subs let primes accelerate systems integration and win larger platform-level contracts, shifting revenue mix toward services and systems engineering.

Key risks are funding cadence and execution cliff scenarios. Congressional appropriation timing and SDA/DoD tranche awards create discrete windows where revenue expectations can be repriced in days; conversely production ramps and flight-test success are multi-quarter to multi-year value drivers. Valuation sensitivity is asymmetric: growth misses on a high-cadence launch/Neutron timeline produce steep multiple compression for growth names, while modest execution beats on profitable, mid‑tier contractors lead to steadier multiple expansion.

From a portfolio construction perspective, this argues a barbell: concentrated, event-driven exposure to the space provider via limited‑risk option structures, paired with an equity-sized, cash‑flow-positive exposure to the low-cost defense manufacturer as a ballast. That pairing captures upside from binary uplifts while limiting drawdowns from scheduling or funding slips.

Key Decisions for Investors

• Long KTOS equity (2–3% NAV): initiate on a sub‑10% intraday pullback; target asymmetric upside of +35–55% over 9–12 months assuming production ramps and margin improvement, with a hard stop at −25% to guard against funding reprofile risk.
• Relative pair — Long KTOS / Short RKLB equal notional (1–2% NAV each leg): horizon 6–12 months to capture relative multiple compression risk in the growth name and steady multiple expansion in the profitable mid‑tier. Close if either leg moves >30% adverse or on a positive binary outcome for RKLB (successful Neutron milestone).
• Event-driven RKLB option spread (0.5–1% NAV): buy a 9–12 month call spread to cap premium paid while retaining upside to successful launches or SDA milestones. Expect a 3x–5x payoff if schedule/flight outcomes are positive; loss limited to premium if delays occur.
• Defensive overlay — overweight primes (LMT/NOC) vs pure launch exposure (RKLB) by 2–3% NAV: use primes as cash-flow‑stable hedges that should benefit from accelerated systems integration even if small‑sat/launcher execution slips — trim on outsized defense budget headlines.